Tag: ESMINT 2023
Embolisation holds “very important, complementary” place in future of AVM treatment
After providing NeuroNews with an overview of the recent history of arteriovenous malformation (AVM) treatment in a previous video interview, Christophe Cognard (Toulouse University...
Growing evidence on AVM interventions contrasts with “horrible” ARUBA data
Recently, NeuroNews caught up with Christophe Cognard (Toulouse University Hospital, Toulouse, France) to discuss the current landscape of arteriovenous malformation (AVM) care. Cognard outlines...
PROST represents “epitome” of scientific rigour, but future trials may follow...
There are multiple components of the PROST randomised controlled trial’s (RCT) design that set it apart from prior studies and make it somewhat unique...
“The tables have turned”—US FDA regulation is becoming the envy of...
Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) revealed the extent of the disparities between the...
Nautilus represents “next evolution” of intrasaccular systems in aneurysm care
The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular...
Vesalio announces presentation of positive CLEAR study results at ESMINT 2023
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...
Cerevasc announces presentation of initial eShunt data at ESMINT 2023
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented...
Women in Neurointervention: How do we boost representation within “male-dominated” field?
Female representation in the neurointerventional world may be growing, but Johanna Fifi (Mount Sinai, New York, USA) and Anne-Christine Januel (Toulouse University Hospital, Toulouse,...
